Journals / Journal of Clinical and Analytical Medicine / 2014 / Cilt: 5 - Sayı: 5

Major Ortopedik Cerrahide %6 Hidroksietil Nişasta ve %4 Jelatin Solüsyonlarının Karşılaştırılması

Comparison of %6 Hydroxyethyl Starch and %4 Gelatine Solutions in Major Orthopedic Surgery

Pages
401–405
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

So, we concluded that bothof two colloid solution can be used safely in patients older than 55years formajor surgery,providing that the patients examined strictly.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Volume replacement is important for maintenance of body functions.
📊
Key Findings & Data:In our studywe aimed to compare the effects of HES, gelatine solutions on coagulationand renal functions in patients undergoing elective major orthopedic surgery.Material and Method: ASA I-II, 55-80years old, fifty patients scheduled underspinal anesthesia.
💡
Conclusion & Impact:So, we concluded that bothof two colloid solution can be used safely in patients older than 55years formajor surgery,providing that the patients examined strictly.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: Volume replacement is important for maintenance of body functions. To achieve this goal, colloids and crystalloids can be preferred. In our studywe aimed to compare the effects of HES, gelatine solutions on coagulationand renal functions in patients undergoing elective major orthopedic surgery.Material and Method: ASA I-II, 55-80years old, fifty patients scheduled underspinal anesthesia. Patients were divided into two groups.Groups HES receivedHES130/0.4 solution 10ml.kg¯¹, Group GEL received same amount of %4gelatine solution starting 30 minutes before the anaesthesia. Mesurements ofhemoglobin(Hb), hematocrit (Hct), platelet, prothrombine time(PT), activatedpartial thromboplastin time (aPTT), %activations, international normalizedratio (INR), sodium, potassium, chlorine, blood urea nirogen(BUN), creatinine,alanine aminotransferase (ALT), aspartate aminotransaminase (AST) wereexamined before and at 4,12,24 hour after surgery. Creatine clearencewas calculated.Hemodynamic parameters, block levels, blood losses, bloodtransfusion requirements and total fluid volume were recorded. Results: Thedemographic data,duration of operations, hemodynamic parameters,blocklevels,blood losses,blood transfusion requirements, (given)total fluid volumewere similar. There were no difference in PT, aPTT, %activations, INR levels,sodium, potassium, ALT, AST, creatinine and creatinine clearence between thegroups. In postoperative 24thhour Hb, Hct values were found lower (p=0.007,p=0.008); platelet counts were found lower at postoperative 12th,24thhour(p=0.028,p=0.007)in Group HES compared with Group GEL.BUN levels werehigher in Group GEL than Group HES at 24hour after surgery(p=0.021).Thechlorine levels were higher in Group HES than Group GEL at 3 postoperative4th and 12thhour (p=0.009,p=0.046). Discussion: Although our administtereddose of HES and gelatine solutions were caused changes in differentparameters, none of them needed treatment. So, we concluded that bothof two colloid solution can be used safely in patients older than 55years formajor surgery,providing that the patients examined strictly.

Özet

Amaç: Vücudun hayati fonksiyonlarının sürdürülmesinde sıvı yönetimi çokönemlidir. Bu amaçla kristalloid veya kolloid solüsyonlar kullanılmaktadır. Çalışmamızda, elektif major ortopedik cerrahi geçirecek hastalarda, %6 hidroksietil nişasta(HES) ve %4 sıvı jelatinin, koagülasyon ve renal parametrelereetkilerini araştırmayı amaçladık. Gereç ve Yöntem: ASA I-II grubu, 55-80yaşarasında, spinal anestezi uygulanan 50hasta çalışmaya alındı. İki gruba ayrılan hastalardan Grup HESe(n=25) anesteziden önce başlanıp toplam miktar 10 ml.kg¯¹ gidecek şekilde HES130/0.4 solüsyonu, Grup JELe(n=21)aynımiktarda %4 jelatin solüsyonu verildi. Hastaların ameliyattan önce, ameliyattan sonra 4.,12. ve 24.saatte hemoglobin(Hb), hematokrit(Hct), trombositsayısı, protrombin zamanı (PT), aktive parsiyel tromboplastin zamanı(aPTT),yüzde aktivasyon değeri, INR, kan üre azotu(BUN), kreatinin, sodyum, potasyum, klor, alanin aminotransferaz (ALT) ve aspartat aminotransaminaz(AST)değerlerine bakıldı.Kreatinin klirensi hesaplandı. Hemodinamik değerler, blokseviyeleri, kan kaybı, kan transfüzyon ihtiyacı,verilen toplam sıvı miktarla- rı kaydedildi. Bulgular: Hastaların demografik verileri, ameliyat süreleri, hemodinamik değerleri, blok düzeyleri, kan kaybı, kan transfüzyon ihtiyacı, verilen toplam sıvı miktarları benzerdi. PT, aPTT, yüzde aktivasyon, INR, sodyum, potasyum, ALT ve AST, kreatinin ve keratinin klirensi değerleri arasında fark yoktu. Hb ve Hct değerleri ameliyattan sonra 24.saatte (p=0.007,p=0.008), trombosit sayısı ise 12. ve 24.saatte Grup HESde Grup JELe göredüşük bulundu(p=0.028, p=0.007). BUN düzeyi ameliyattan sonra 24.saatte Grup JELde Grup HESe göre daha yüksek bulundu (p=0.021). Klor düzeyleri ameliyattan 1 sonra 4. ve 12.saatte Grup HESde Grup JELden daha yüksekbulundu (p=0.009, p=0.046). Tartışma: Uyguladığımız dozlarda HES 130/0.4ve %4 modifiye sıvı jelatin solüsyonları farklı parametrelerde değişikliklereneden olsa da ölçülen değerler tedavi gerektirmedi. Bu nedenle her iki kolloidsolüsyonun 55 yaş üstü hastalar ve büyük cerrahi girişimlerde, hastaların dikkatli takip edilmesi koşuluyla güvenle kullanılabileceği kanısındayız.

🔖

Cite This Article

YANLI, Y., BAKAN, N., ÖZDEMİR, M., BOZKURT, Ö., AKINCI, N. Ö. (2022). Major Ortopedik Cerrahide %6 Hidroksietil Nişasta ve %4 Jelatin Solüsyonlarının Karşılaştırılması. Journal of Clinical and Analytical Medicine, Cilt: 5 - Sayı: 5, 401–405. https://ajindex.com/articles/561492

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Van der Linden PJ, De Hert SG, Deraedt D, Cromheecke S, De Decker K, De Paep R et al. Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for volume expansion in cardiac surgery patients: the effects on perioperative bleeding and transfusion needs. Anesth Analg 2005;101(3):629-34
  2. Boldt J, Priebe HJ. Intravascular volume replacement therapy with synthetic colloids: is there an influence on renal function? Anesth Analg 2003;96(2):376-82
  3. Kaya AG, Demir A. Geriatrik anestezi. In: Başar HT, editor. Organ sistemleri ve anestezi. 1st ed. Ankara: Güneş Tıp Kitapevleri; 2010.p.205
  4. Davidson IJ. Renal impact of fluid management with colloids: a comperative rewiew. Eur J Anaesthesiol 2006;23(9):721-38
  5. Fenger-Ericsen C, Rasmussen CH, Jensen TK, Anker- Møller E, Heslop J, Frøkiær J et al. Renal effects of hypotensive anaesthesia in combination with acute normo- volemic haemodilution with hydroxyethyl starch 130/0.4 or isotonic saline. Acta Anaesthesiol Scand 2005;49(7):969-74
  6. Niemi TT, Suojaranta-Ylinen RT, Kukkonen SI, Kuitunen AH. Gelatin and hydrox- yethylstarch, but not albumin, impair hemostasis after cardiac surgery. Anesth Analg 2006;102(4):998-1006
  7. Sakr Y, Payen D, Reinhart K, Sipmann FS, Zavala E, Bewley J et al.Effects of hydroxyethyl starch administration on renal function in critically ill patients. Br J Anaesth 2007;98(2):216-24
  8. Jungheinrich C, Scharpf R, Wargenau M, Bepperling F, Baron JF. The pharmo- cokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%, 500 ml) in mild-to-severe renal impairment. Anesth Analg 2002;95(3):544-51
  9. Fries D, Innerhofer P, Klingler A, Berresheim U, Mittermayr M, Calatzis A et al. The effect of combined administration of colloids and lactated Ringer’s solution on the coagulation system: an in vitro study using thrombelastograph coagulation analysis (ROTEG®). Anesth Analg 2002;94(5):1280-7
  10. Kozek-Langenecker SA, Jungheinrich C, Sauermann W, Van der Linden P. The effects of hydroxyethyl starch 130/0.4 (6%) on blood loss and use of bloood products in major surgery: a pooled analysis of randomized clinical trials. Anesth Analg 2008;107(2):382-90
  11. Mittermayr M, Streif W, Haas T, Fries D, Velik-Salchner C, Klingler A et al. Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: The role of fibrinogen administration. Anesth Analg 2007;105(4):905-17
  12. Schramko AA, Suojaranta-Ylinen RT, Kuitunen A